Chemoradiation in the Management of Esophageal Cancer

Cancer Statistics, 2005

2005 • 5,487 citations

Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck

2006 • 4,800 citations

Combined Chemotherapy and Radiotherapy Compared with Radiotherapy Alone in Patients with Cancer of the Esophagus

1992 • 2,028 citations

A Comparison of Multimodal Therapy and Surgery for Esophageal Adenocarcinoma

1996 • 1,952 citations

Chemoradiotherapy of Locally Advanced Esophageal Cancer

1999 • 1,864 citations

Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial

2002 • 1,419 citations

Chemoradiotherapy Followed by Surgery Compared with Surgery Alone in Squamous-Cell Cancer of the Esophagus

1997 • 1,373 citations

Chemotherapy Followed by Surgery Compared with Surgery Alone for Localized Esophageal Cancer

1998 • 1,344 citations

INT 0123 (Radiation Therapy Oncology Group 94-05) Phase III Trial of Combined-Modality Therapy for Esophageal Cancer: High-Dose Versus Standard-Dose Radiation Therapy

2002 • 1,301 citations

Randomized Trial of Preoperative Chemoradiation Versus Surgery Alone in Patients With Locoregional Esophageal Carcinoma

2001 • 1,282 citations

Chemoradiation With and Without Surgery in Patients With Locally Advanced Squamous Cell Carcinoma of the Esophagus

2005 • 1,275 citations

Chemoradiation Followed by Surgery Compared With Chemoradiation Alone in Squamous Cancer of the Esophagus: FFCD 9102

2007 • 1,193 citations

Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis

2007 • 1,160 citations

INT 0123 (Radiation Therapy Oncology Group 94-05) Phase III Trial of Combined-Modality Therapy for Esophageal Cancer: High-Dose Versus Standard-Dose Radiation Therapy

2002 • 1,039 citations

Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial

2005 • 919 citations

A randomized study of chemotherapy, radiation therapy, and surgery versus surgery for localized squamous cell carcinoma of the esophagus

1994 • 621 citations

Epidemiology and Pathogenesis of Esophageal Cancer

2006 • 522 citations

Epigenetic patterns in the progression of esophageal adenocarcinoma.

2001 • 502 citations

Pharmacologic requirements for obtaining sensitization of human tumor cells in vitro to combined 5-fluorouracil or ftorafur and X rays

1982 • 391 citations

Combined treatment of radiation and cisdiamminedichloroplatinum (II): a review of experimental and clinical data

1987 • 358 citations

Radiotherapy As Primary Treatment for Stage IE and IIE Nasal Natural Killer/T-Cell Lymphoma

2005 • 346 citations

Postoperative radiotherapy for carcinoma of the esophagus: a prospective, randomized controlled study.

1993 • 341 citations

Are Squamous and Adenocarcinomas of the Esophagus the Same Disease?

2006 • 310 citations

The epidermal growth factor receptor mediates radioresistance

2003 • 296 citations

Epidemiology of esophageal adenocarcinoma

2005 • 294 citations

Utility of PET, CT, and EUS to Identify Pathologic Responders in Esophageal Cancer

2004 • 294 citations

2‐Fluoro‐2‐deoxy‐D‐glucose positron emission tomography imaging is predictive of pathologic response and survival after preoperative chemoradiation in patients with esophageal carcinoma

2004 • 265 citations

Combined chemoradiotherapy vs. radiotherapy alone for early stage squamous cell carcinoma of the esophagus: a study of the eastern cooperative oncology group

1998 • 262 citations

Enhancement of antitumor activity of ionizing radiation by combined treatment with the selective epidermal growth factor receptor-tyrosine kinase inhibitor ZD1839 (Iressa).

2002 • 245 citations

Barrett's oesophagus: from metaplasia to dysplasia and cancer

2005 • 180 citations

Targeting the epidermal growth factor receptor in radiotherapy: radiobiological mechanisms, preclinical and clinical results

2004 • 178 citations

Genetic Variations in Radiation and Chemotherapy Drug Action Pathways Predict Clinical Outcomes in Esophageal Cancer

2006 • 170 citations

Gene Expression Profiling of Localized Esophageal Carcinomas: Association With Pathologic Response to Preoperative Chemoradiation

2005 • 168 citations

Preoperative radiotherapy in esophageal carcinoma: a meta-analysis using individual patient data (oesophageal cancer collaborative group)

1998 • 162 citations

Final report of Intergroup Trial 0122 (ECOG PE-289, RTOG 90-12): Phase II trial of neoadjuvant chemotherapy plus concurrent chemotherapy and high-dose radiation for squamous cell carcinoma of the esophagus

1999 • 142 citations

The molecular biology of esophageal adenocarcinoma

2005 • 138 citations

Prognostic Factors in Adenocarcinoma of the Esophagus or Gastroesophageal Junction

2006 • 131 citations

The epidemic of esophageal adenocarcinoma

2002 • 125 citations

Genetic pathways involved in the progression of Barrett's metaplasia to adenocarcinoma

2002 • 123 citations

Epidermal growth factor receptor, p53 mutation, and pathological response predict survival in patients with locally advanced esophageal cancer treated with preoperative chemoradiotherapy.

2003 • 122 citations

Endoscopic Ultrasound Does Not Accurately Assess Pathologic Stage of Esophageal Cancer after Neoadjuvant Chemoradiotherapy

2000 • 120 citations

18FDG uptake during induction chemoradiation for oesophageal cancer fails to predict histomorphological tumour response

2006 • 120 citations

Gene expression profile changes in initiation and progression of squamous cell carcinoma of esophagus

2001 • 99 citations

Endosonographic assessment of multimodality therapy predicts survival of esophageal carcinoma patients

2000 • 98 citations

Gene expression profiling of esophageal cancer: Comparative analysis of Barrett's esophagus, adenocarcinoma, and squamous cell carcinoma

2007 • 94 citations

Survival of patients with carcinoma of the esophagus treated with combined-modality therapy

1993 • 89 citations

The importance of Pet in the diagnosis and response evaluation of esophageal cancer

2006 • 81 citations

Mechanisms of Disease: radiosensitization by epidermal growth factor receptor inhibitors

2004 • 67 citations

DNA topoisomerase I-targeting drugs as radiation sensitizers.

1999 • 67 citations

Gene Expression Profiling in Human Esophageal Cancers Using cDNA Microarray

2001 • 62 citations

5-Fluorouracil radiation sensitization — A brief review

1989 • 56 citations

Fluoropyrimidine-Radiation Interactions in Cells and Tumors.

1997 • 53 citations

Fluoropyrimidine-radiation interactions in cells and tumors

1997 • 51 citations

Radiobiological effects of docetaxel (Taxotere): a potential radiation sensitizer

1999 • 50 citations

The Role of Integrated Computed Tomography Positron-Emission Tomography in Esophageal Cancer: Staging and Assessment of Therapeutic Response

2006 • 47 citations

Aberrant <I>p16</I> Methylation, a Possible Epigenetic Risk Factor in Familial Esophageal Squamous Cell Carcinoma

2005 • 44 citations

A randomized trial of chemoradiotherapy versus surgery alone in patients with resectable esophageal cancer

2007 • 35 citations

Will worms really cure Crohn's disease?

2004 • 32 citations

Methylation in esophageal carcinogenesis

2006 • 28 citations

Comparative genomic hybridization: comparison between esophageal squamous cell carcinoma and gastric cardia adenocarcinoma from a high-incidence area for both cancers in Henan, northern China

2006 • 24 citations

E1201: An Eastern Cooperative Oncology Group (ECOG) randomized phase II trial of neoadjuvant preoperative paclitaxel/cisplatin/RT or irinotecan/cisplatin/RT in endoscopy with ultrasound (EUS) staged adenocarcinoma of the esophagus

2007 • 16 citations

Epidemiology and Molecular Biology of Barrett Esophagus

2005 • 12 citations

Radiation Enhancement by 9‐Aminocamptothecin

1996 • 9 citations

[Association of taxanes and radiotherapy: preclinical and clinical studies].

2004 • 9 citations

Evolving Role of 18F-Fluorodeoxyglucose Positron Emission Tomography in the Management of Esophageal Carcinoma

2006 • 7 citations

143

2006 • 6 citations

Rechute locale isolée après traitement conservateur pour un carcinome mammaire de stade I ou II, à propos de 57 patientes

2004 • 5 citations